Show simple item record

dc.contributor.authorCarracedo Pérez, Arkaitz ORCID
dc.date.accessioned2023-06-28T18:18:11Z
dc.date.available2023-06-28T18:18:11Z
dc.date.issued2023-06
dc.identifier.citationMolecular Oncology 17(6) : 921-924 (2023)es_ES
dc.identifier.issn1574-7891
dc.identifier.issn1878-0261
dc.identifier.urihttp://hdl.handle.net/10810/61779
dc.description.abstractThe process of cellular transformation encompasses the acquisition of key and distinctive features, commonly known as hallmarks of cancer. These hallmarks are supported by tumor-intrinsic molecular alterations, as well as changes in the microenvironment. Cellular metabolism represents one of the most intimate connections between a cell and the environment. In turn, metabolic adaptation is a research field of increasing interest in cancer biology. In this viewpoint, I will provide a panoramic perspective of the relevance and repercussions of metabolic alterations in tumors with nonexhaustive illustrative examples and I will speculate about the prospects of cancer metabolism research.es_ES
dc.description.sponsorshipOur work is supported by the Basque Department of Industry, Tourism and Trade (Elkartek), the MICINN (PID2019-108787RB-I00 (FEDER/EU); Severo Ochoa Excellence Accreditation MCIN/AEI/10.13039/501100011033 for grant CEX2021-001136-S), European Training Networks Project (H2020-MSCA-ITN-2020 955534), the AECC (GCTRA18006CARR), CRIS Foundation Against Cancer (PR_EX_2021-22), La Caixa Foundation (ID 100010434), under the agreement LCF/PR/HR17/, Jesús Serra Foundation, Vencer el Cáncer Foundation, and the European Research Council (Consolidator Grant 819242). CIBERONC was co-funded with FEDER Funds and funded by ISCIII.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/PID2019-108787RB-I00es_ES
dc.relationinfo:eu-repo/grantAgreement/MICINN/CEX2021-001136-Ses_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/955534es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectanabolismes_ES
dc.subjectcancer metabolismes_ES
dc.subjectmetabolic vulnerabilityes_ES
dc.subjecttumor microenvironmentes_ES
dc.titleMetabolism in the tumor cell and beyondes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2023 The Author. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.13467es_ES
dc.identifier.doi10.1002/1878-0261.13467
dc.contributor.funderEuropean Commission
dc.departamentoesBioquímica y biología moleculares_ES
dc.departamentoeuBiokimika eta biologia molekularraes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2023 The Author. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as © 2023 The Author. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.